<bill session="108" type="h" number="4790" updated="2023-01-14T22:48:15Z">
  <state datetime="2004-07-09">REFERRED</state>
  <status>
    <introduced datetime="2004-07-09"/>
  </status>
  <introduced datetime="2004-07-09"/>
  <titles>
    <title type="display">Drug Importation Promotion and Safety Act</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to authorize the importation of prescription drugs from Canada and certain other countries, and for other purposes.</title>
    <title type="short" as="introduced">Drug Importation Promotion and Safety Act</title>
  </titles>
  <sponsor bioguide_id="J000110"/>
  <cosponsors/>
  <actions>
    <action datetime="2004-07-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2004-07-09" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2004-07-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Accreditation (Medical care)"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Advertising"/>
    <term name="Australia"/>
    <term name="Business records"/>
    <term name="Canada"/>
    <term name="Charitable contributions"/>
    <term name="Civil Rights and Liberties, Minority Issues"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Deceptive advertising"/>
    <term name="Defective products"/>
    <term name="Department of Health and Human Services"/>
    <term name="Directories"/>
    <term name="Drug abuse"/>
    <term name="Drug industry"/>
    <term name="Drug interactions"/>
    <term name="Drugs"/>
    <term name="East Asia"/>
    <term name="Economics and Public Finance"/>
    <term name="Electronic commerce"/>
    <term name="Electronic data interchange"/>
    <term name="Electronic government information"/>
    <term name="Europe"/>
    <term name="European Union"/>
    <term name="Executive reorganization"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Government Operations and Politics"/>
    <term name="Government contractors"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Grants-in-aid"/>
    <term name="Health information systems"/>
    <term name="Identification devices"/>
    <term name="Import restrictions"/>
    <term name="Imports"/>
    <term name="Injunctions"/>
    <term name="Intellectual property"/>
    <term name="Interactive media"/>
    <term name="Internet"/>
    <term name="Japan"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Liability (Law)"/>
    <term name="Licenses"/>
    <term name="Medical records"/>
    <term name="Medication abuse"/>
    <term name="New Zealand"/>
    <term name="Oceania"/>
    <term name="Packaging"/>
    <term name="Patients' rights"/>
    <term name="Performance measurement"/>
    <term name="Pharmacies"/>
    <term name="Pharmacists"/>
    <term name="Physicians"/>
    <term name="Prescription pricing"/>
    <term name="Product counterfeiting"/>
    <term name="Product safety"/>
    <term name="Right of privacy"/>
    <term name="Science, Technology, Communications"/>
    <term name="Switzerland"/>
    <term name="Telephone"/>
    <term name="Web sites"/>
    <term name="Wholesale trade"/>
  </subjects>
  <amendments/>
  <summary date="2005-01-10T15:44:48Z" status="Introduced in House">Drug Importation Promotion and Safety Act - Amends the Federal Food, Drug, and Cosmetic Act to establish the Office of Drug Importation Promotion and Safety.

Allows a registered drug importation facility, pharmacy, Internet pharmacy, or wholesaler to import a Food and Drug Administration (FDA)-approved prescription drug from Canada or a permitted country.

Prohibits the commingling of domestic and imported prescription drugs.

Requires a pharmacy or Internet pharmacy that dispenses an imported prescription drug to label such drug accordingly.

Allows individuals to import prescription drugs from: (1) a registered Internet pharmacy; or (2) licensed pharmacies for personal use.

Allows the Secretary to suspend importation of a particular drug from a particular facility, pharmacy, wholesaler, or country.

Allows licensed Internet pharmacies to dispense prescription drugs. Sets forth licensing requirements for Internet pharmacies.

Makes interactive computer service providers and advertising service providers liable for violations under this Act if such a provider accepts advertising: (1) for a prescription drug from an unlicensed Internet pharmacy; or (2) stating that an individual does not need a prescription to obtain a prescription drug.

Requires the Secretary to: (1) require the adoption and use of electronic track and trace technology to identify each sale, purchase, or trade of a prescription drug; and (2) establish a network to provide prompt notification of counterfeit drugs and to facilitate the identification and reporting of such drugs.

Sets forth requirements for wholesalers, including requirements to identify the immediately previous distributor of record and all previous sales, purchases, or trades for imported prescription drugs.</summary>
</bill>
